{"entity":{"type":"insider","cik":"0001820066","url":"/insider/0001820066","json_url":"/insider/0001820066.json","name":"Santos David A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":3,"first":"2023-02-06","last":"2025-02-06","span_basis":"filed_date"},"name_variants":[{"name":"Santos David A","source":"filing","n_filings":3,"first_seen":"2023-02-06","last_seen":"2025-02-06"}],"transactions":[{"id":4746662,"accession":"0000905148-25-000412","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-25-000412","line_url":"/filing/0000905148-25-000412#line-2","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":"0001820066","owner_name":"Santos David A","owner_display_name":"Santos David A","owner_url":"/insider/0001820066","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1796.0,"shares_display":"1,796","price_per_share":21.926,"price_display":"21.93","price_state":"stated","total_value":39379.096,"total_display":"39,379.10","total_whole":"39,379","shares_owned_after":51704.0,"shares_owned_after_display":"51,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-06","scope":"insider"},{"id":4746655,"accession":"0000905148-25-000412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-25-000412","line_url":"/filing/0000905148-25-000412#line-1","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":"0001820066","owner_name":"Santos David A","owner_display_name":"Santos David A","owner_url":"/insider/0001820066","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2125.0,"shares_display":"2,125","price_per_share":20.921,"price_display":"20.92","price_state":"stated","total_value":44457.125,"total_display":"44,457.12","total_whole":"44,457","shares_owned_after":53500.0,"shares_owned_after_display":"53,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-06","scope":"insider"},{"id":2059116,"accession":"0000905148-24-000447","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-24-000447","line_url":"/filing/0000905148-24-000447#line-2","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":"0001820066","owner_name":"Santos David A","owner_display_name":"Santos David A","owner_url":"/insider/0001820066","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8918.0,"shares_display":"8,918","price_per_share":1.14,"price_display":"1.14","price_state":"stated","total_value":10166.52,"total_display":"10,166.52","total_whole":"10,167","shares_owned_after":349093.0,"shares_owned_after_display":"349,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-05","filed_date":"2024-02-06","scope":"insider"},{"id":2059114,"accession":"0000905148-24-000447","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-000447","line_url":"/filing/0000905148-24-000447#line-1","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":"0001820066","owner_name":"Santos David A","owner_display_name":"Santos David A","owner_url":"/insider/0001820066","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5601.0,"shares_display":"5,601","price_per_share":1.13,"price_display":"1.13","price_state":"stated","total_value":6329.13,"total_display":"6,329.13","total_whole":"6,329","shares_owned_after":358011.0,"shares_owned_after_display":"358,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-06","scope":"insider"},{"id":7894667,"accession":"0001140361-23-004733","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-004733","line_url":"/filing/0001140361-23-004733#line-1","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":"0001820066","owner_name":"Santos David A","owner_display_name":"Santos David A","owner_url":"/insider/0001820066","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5388.0,"shares_display":"5,388","price_per_share":1.6602,"price_display":"1.66","price_state":"stated","total_value":8945.1576,"total_display":"8,945.16","total_whole":"8,945","shares_owned_after":144612.0,"shares_owned_after_display":"144,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-02","filed_date":"2023-02-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001034842","name":"RIGEL PHARMACEUTICALS INC","url":"/issuer/0001034842","role":"Officer (EVP, Chief Commercial Officer)","n_filings":3,"first_seen":"2023-02-06","last_seen":"2025-02-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001820066","retrieved_at":"2026-08-25T02:40:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}